These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

844 related items for PubMed ID: 19778673

  • 1. Optimal medical therapy with or without percutaneous coronary intervention in older patients with stable coronary disease: a pre-specified subset analysis of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation) trial.
    Teo KK, Sedlis SP, Boden WE, O'Rourke RA, Maron DJ, Hartigan PM, Dada M, Gupta V, Spertus JA, Kostuk WJ, Berman DS, Shaw LJ, Chaitman BR, Mancini GB, Weintraub WS, COURAGE Trial Investigators.
    J Am Coll Cardiol; 2009 Sep 29; 54(14):1303-8. PubMed ID: 19778673
    [Abstract] [Full Text] [Related]

  • 2. Impact of optimal medical therapy with or without percutaneous coronary intervention on long-term cardiovascular end points in patients with stable coronary artery disease (from the COURAGE Trial).
    Boden WE, O'Rourke RA, Teo KK, Maron DJ, Hartigan PM, Sedlis SP, Dada M, Labedi M, Spertus JA, Kostuk WJ, Berman DS, Shaw LJ, Chaitman BR, Mancini GB, Weintraub WS, COURAGE Trial Investigators.
    Am J Cardiol; 2009 Jul 01; 104(1):1-4. PubMed ID: 19576311
    [Abstract] [Full Text] [Related]

  • 3. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy.
    Shaw LJ, Berman DS, Maron DJ, Mancini GB, Hayes SW, Hartigan PM, Weintraub WS, O'Rourke RA, Dada M, Spertus JA, Chaitman BR, Friedman J, Slomka P, Heller GV, Germano G, Gosselin G, Berger P, Kostuk WJ, Schwartz RG, Knudtson M, Veledar E, Bates ER, McCallister B, Teo KK, Boden WE, COURAGE Investigators.
    Circulation; 2008 Mar 11; 117(10):1283-91. PubMed ID: 18268144
    [Abstract] [Full Text] [Related]

  • 4. Impact of an initial strategy of medical therapy without percutaneous coronary intervention in high-risk patients from the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial.
    Maron DJ, Spertus JA, Mancini GB, Hartigan PM, Sedlis SP, Bates ER, Kostuk WJ, Dada M, Berman DS, Shaw LJ, Chaitman BR, Teo KK, O'Rourke RA, Weintraub WS, Boden WE, COURAGE Trial Research Group.
    Am J Cardiol; 2009 Oct 15; 104(8):1055-62. PubMed ID: 19801024
    [Abstract] [Full Text] [Related]

  • 5. Optimal medical therapy with or without percutaneous coronary intervention for patients with stable coronary artery disease and chronic kidney disease.
    Sedlis SP, Jurkovitz CT, Hartigan PM, Goldfarb DS, Lorin JD, Dada M, Maron DJ, Spertus JA, Mancini GB, Teo KK, O'Rourke RA, Boden WE, Weintraub WS, COURAGE Study Investigators.
    Am J Cardiol; 2009 Dec 15; 104(12):1647-53. PubMed ID: 19962469
    [Abstract] [Full Text] [Related]

  • 6. Evolving concepts in selecting optimal strategies for the management of patients with stable coronary disease: pharmacologic or revascularization therapy.
    Tandar A, Boden WE.
    Curr Opin Cardiol; 2009 Nov 15; 24(6):591-5. PubMed ID: 19752728
    [Abstract] [Full Text] [Related]

  • 7. Intensive multifactorial intervention for stable coronary artery disease: optimal medical therapy in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial.
    Maron DJ, Boden WE, O'Rourke RA, Hartigan PM, Calfas KJ, Mancini GB, Spertus JA, Dada M, Kostuk WJ, Knudtson M, Harris CL, Sedlis SP, Zoble RG, Title LM, Gosselin G, Nawaz S, Gau GT, Blaustein AS, Bates ER, Shaw LJ, Berman DS, Chaitman BR, Weintraub WS, Teo KK, COURAGE Trial Research Group.
    J Am Coll Cardiol; 2010 Mar 30; 55(13):1348-58. PubMed ID: 20338496
    [Abstract] [Full Text] [Related]

  • 8. Cost-effectiveness of percutaneous coronary intervention in optimally treated stable coronary patients.
    Weintraub WS, Boden WE, Zhang Z, Kolm P, Zhang Z, Spertus JA, Hartigan P, Veledar E, Jurkovitz C, Bowen J, Maron DJ, O'Rourke R, Dada M, Teo KK, Goeree R, Barnett PG, Department of Veterans Affairs Cooperative Studies Program No. 424 (COURAGE Trial) Investigators and Study Coordinators.
    Circ Cardiovasc Qual Outcomes; 2008 Sep 30; 1(1):12-20. PubMed ID: 20031783
    [Abstract] [Full Text] [Related]

  • 9. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.
    Hueb W, Lopes NH, Gersh BJ, Soares P, Machado LA, Jatene FB, Oliveira SA, Ramires JA.
    Circulation; 2007 Mar 06; 115(9):1082-9. PubMed ID: 17339566
    [Abstract] [Full Text] [Related]

  • 10. Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
    Alexander KP, Newby LK, Armstrong PW, Cannon CP, Gibler WB, Rich MW, Van de Werf F, White HD, Weaver WD, Naylor MD, Gore JM, Krumholz HM, Ohman EM, American Heart Association Council on Clinical Cardiology, Society of Geriatric Cardiology.
    Circulation; 2007 May 15; 115(19):2570-89. PubMed ID: 17502591
    [Abstract] [Full Text] [Related]

  • 11. Clinical implications of the BARI 2D and COURAGE trials: the evolving role of percutaneous coronary intervention.
    Holper EM, Addo T.
    Coron Artery Dis; 2010 Nov 15; 21(7):397-401. PubMed ID: 20634692
    [Abstract] [Full Text] [Related]

  • 12. Design and rationale of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial Veterans Affairs Cooperative Studies Program no. 424.
    Boden WE, O'rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk W, Knudtson M, Dada M, Casperson P, Harris CL, Spertus JA, Shaw L, Chaitman BR, Mancini GB, Berman DS, Weintraub WS, COURAGE trial coprincipal investigators and study coordinators.
    Am Heart J; 2006 Jun 15; 151(6):1173-9. PubMed ID: 16781214
    [Abstract] [Full Text] [Related]

  • 13. Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: a meta-analysis.
    Katritsis DG, Ioannidis JP.
    Circulation; 2005 Jun 07; 111(22):2906-12. PubMed ID: 15927966
    [Abstract] [Full Text] [Related]

  • 14. Management of chronic coronary disease: is the pendulum returning to equipoise?
    Boden WE.
    Am J Cardiol; 2008 May 22; 101(10A):69D-74D. PubMed ID: 18474277
    [Abstract] [Full Text] [Related]

  • 15. Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial.
    Daemen J, Kuck KH, Macaya C, LeGrand V, Vrolix M, Carrie D, Sheiban I, Suttorp MJ, Vranckx P, Rademaker T, Goedhart D, Schuijer M, Wittebols K, Macours N, Stoll HP, Serruys PW, ARTS-II Investigators.
    J Am Coll Cardiol; 2008 Dec 09; 52(24):1957-67. PubMed ID: 19055986
    [Abstract] [Full Text] [Related]

  • 16. The cost-effectiveness of percutaneous coronary intervention as a function of angina severity in patients with stable angina.
    Zhang Z, Kolm P, Boden WE, Hartigan PM, Maron DJ, Spertus JA, O'Rourke RA, Shaw LJ, Sedlis SP, Mancini GB, Berman DS, Dada M, Teo KK, Weintraub WS.
    Circ Cardiovasc Qual Outcomes; 2011 Mar 09; 4(2):172-82. PubMed ID: 21304091
    [Abstract] [Full Text] [Related]

  • 17. The impact of age on outcomes after coronary artery bypass surgery versus stent-assisted percutaneous coronary intervention: one-year results from the Stent or Surgery (SoS) trial.
    Zhang Z, Mahoney EM, Spertus JA, Booth J, Nugara F, Kolm P, Stables RH, Weintraub WS.
    Am Heart J; 2006 Dec 09; 152(6):1153-60. PubMed ID: 17161069
    [Abstract] [Full Text] [Related]

  • 18. Optimal medical therapy with or without percutaneous coronary intervention in women with stable coronary disease: A pre-specified subset analysis of the Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation (COURAGE) trial.
    Acharjee S, Teo KK, Jacobs AK, Hartigan PM, Barn K, Gosselin G, Tanguay JF, Maron DJ, Kostuk WJ, Chaitman BR, Mancini GB, Spertus JA, Dada MR, Bates ER, Booth DC, Weintraub WS, O'Rourke RA, Boden WE, COURAGE Trial Research Group.
    Am Heart J; 2016 Mar 09; 173():108-17. PubMed ID: 26920603
    [Abstract] [Full Text] [Related]

  • 19. Six-month outcomes after single- and multi-lesion percutaneous coronary intervention: results from the ROSETTA registry.
    Goldman LE, Okrainec K, Eisenberg MJ, Schechter D, Lefkovits J, Goudreau E, Deligonul U, Mak KH, Del Core M, Duerr R, Huynh T, Smilovitch M, Sedlis S, Brown DL, Brieger D, ROSETTA Investigators.
    Can J Cardiol; 2004 May 01; 20(6):608-12. PubMed ID: 15152290
    [Abstract] [Full Text] [Related]

  • 20. Non-ST-elevation myocardial infarction patients who present during off hours have higher risk profiles and are treated less aggressively, but their outcomes are not worse: a report from Can Rapid Risk Stratification of Unstable Angina Patients Suppress ADverse Outcomes with Early Implementation of the ACC/AHA Guidelines CRUSADE initiative.
    Pollack CV, Hollander JE, Chen AY, Peterson ED, Bangalore S, Peacock FW, Cannon CP, Canto JG, Gibler BW, Ohman ME, Roe MT.
    Crit Pathw Cardiol; 2009 Mar 01; 8(1):29-33. PubMed ID: 19258835
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.